Press Releases

Cleerly to Debut Customizable Full Text Reports and Present New AI-QCT Research at SCCT2026

Cleerly — Tue, 07 Jul 2026 13:00:04 GMT

New Full Text Report Configurability and Six Scientific Presentations at the 21st Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography

MemorialCare Heart & Vascular Institute Becomes First Hospital in Los Angeles County to Offer Cleerly AI-Powered Heart Disease Analysis, Quantifying Total Plaque Volume and Soft Plaque

Cleerly — Wed, 20 May 2026 15:59:59 GMT

Systemwide launch brings AI powered assessment to Coronary CTA’s to MemorialCare’s Long Beach Medical Center, Orange Coast Medical Center, and Saddleback Medical Center.

Cleerly's Statement on Heartflow’s lawsuit to limit competition

Cleerly — Fri, 17 Apr 2026 12:00:01 GMT

At Cleerly, our mission has always been clear and unwavering: to create a world without heart attacks. Every decision we make – from the innovative products we launch, to our landmark clinical studies, to every person we hire – is made with that goal top of mind.

Cleerly to Debut Cleerly PREVIEW and Showcase New AI-QCT Research at ACC.26

Cleerly — Wed, 25 Mar 2026 16:29:59 GMT

New Product Enhancement and Four Scientific Presentations to Highlight Cleerly's Presence at the 75th Annual Scientific Session & Expo of the American College of Cardiology

Cleerly AI-QCT Demonstrates High Agreement With Invasive IVUS in INVICTUS Registry

Cleerly — Fri, 20 Mar 2026 16:14:59 GMT

Multicenter INVICTUS Registry Demonstrates Strong Correlation Between Noninvasive AI-QCT and Invasive IVUS for Coronary Plaque Quantification

Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis

Cleerly — Tue, 06 Jan 2026 19:00:00 GMT

Major Insurer Joins UnitedHealthcare, Cigna, and Humana in Covering Cleerly's AI-QCT Technology as Industry Momentum Builds with 86+ Million Lives Now Covered

CVCT 2025: Cleerly Late-Breaking Science Identifies Thresholds of High Plaque Burden in Non-Obstructive CAD that May Carry Greater Risk Than Obstructive Disease

Cleerly — Mon, 15 Dec 2025 18:00:00 GMT

Sixth late-breaking presentation from CONFIRM2 Registry demonstrates 12-fold risk gradient based on total plaque burden

Cleerly Unveils PowerScribe Integration and Lesion-Level Reporting at RSNA 2025

Cleerly — Wed, 26 Nov 2025 15:00:02 GMT

New additions streamline data transfer with lesion details, helping make information more accessible for care teams

AHA 2025 Late-Breaking Science: Cleerly’s AI Atherosclerosis Quantification Outperforms Traditional Risk Scoring

Cleerly — Mon, 10 Nov 2025 15:11:31 GMT

New Data from the CONFIRM2 International Registry Shows AI-QCT Improves Prediction of Major Cardiovascular Events from 62% to 75%

TCT 2025 Late-Breaking Science: Quantitative Assessment of Non-Calcified Plaque Volume Drives Risk for Myocardial Infarction and Death

Cleerly — Mon, 27 Oct 2025 14:00:00 GMT

CONFIRM2 Registry Demonstrates Prognostic Value of AI-Based Plaque Characterization Beyond Stenosis Severity